Viral vector vaccines use a version of a mild virus to safely deliver instructions in the form of genetic code to our body cells. These instructions enable your body to produce a harmless piece of the ...
Three coronavirus vaccine candidates now lead the pack. Moderna, a Massachusetts-based biotech firm, released updated results from its late-stage clinical trial on Monday. The data so far show its ...
The other COVID-19 vaccines authorised for use in the EU are mRNA vaccines (Pfizer/BioNTech and Moderna) or viral vector vaccines (AstraZeneca and Janssen).
AZD1222, developed by the University of Oxford and licenced to AstraZeneca, was among the first vaccines created to protect against COVID-19. A non -replicating viral vector vaccine which was ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results